Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

about

Ceritinib Enhances the Efficacy of Trametinib in BRAF/NRAS-Wild-Type Melanoma Cell Lines.Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance

P2860

Q50042437-46FFA9CD-3934-40D0-ABE1-B99EE09B102E Q58802587-C4191C49-10F1-482E-952C-01F066D2B3E4

P2860

Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

Item

http://www.wikidata.org/entity/Q47678215

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

@en

Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

@nl

type

Item

label

Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

@en

Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

@nl

prefLabel

Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

@en

Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

@nl

P1476

Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

@en

P2093

Bin Fang

http://www.w3.org/2001/XMLSchema#string

Eric B Haura

http://www.w3.org/2001/XMLSchema#string

Fumi Kinose

http://www.w3.org/2001/XMLSchema#string

John M Koomen

http://www.w3.org/2001/XMLSchema#string

Lily L Remsing Rix

http://www.w3.org/2001/XMLSchema#string

Paul A Stewart

http://www.w3.org/2001/XMLSchema#string

Theresa A Boyle

http://www.w3.org/2001/XMLSchema#string

P2860

Finding community structure in very large networks

Focal adhesion kinase (FAK) activates and stabilizes IGF-1 receptor

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non-Small Cell Lung Cancer

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Ceritinib in ALK-rearranged non-small-cell lung cancer.

Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics

Uncovering the overlapping community structure of complex networks in nature and society

Network pharmacology: the next paradigm in drug discovery

Fast unfolding of communities in large networks

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

P2888

nchembio.2489

P304

1222-1231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCHEMBIO.2489

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brent M Kuenzi

Uwe Rix

Annamarie T Bryant

P577

2017-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28991240

http://www.w3.org/2001/XMLSchema#string

P921

ceritinib

P932

5909815

http://www.w3.org/2001/XMLSchema#string

Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

about

P2860

P2860

Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932